DANIEL LEUNG to Liver Diseases
This is a "connection" page, showing publications DANIEL LEUNG has written about Liver Diseases.
Connection Strength
4.333
-
Risk factors for more rapid progression of severe liver fibrosis in children with cystic fibrosis-related liver disease: A multi-center study validated by liver biopsy. Liver Int. 2023 06; 43(6):1277-1286.
Score: 0.638
-
Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease. Hepatology. 2023 02 01; 77(2):530-545.
Score: 0.620
-
The Emergence of Elastography for Cystic Fibrosis Liver Disease. J Cyst Fibros. 2020 05; 19(3):339-341.
Score: 0.521
-
Obliterative Portal Venopathy Without Cirrhosis Is Prevalent in Pediatric Cystic Fibrosis Liver Disease With Portal Hypertension. Clin Gastroenterol Hepatol. 2019 09; 17(10):2134-2136.
Score: 0.470
-
The intestinal microbiome and paediatric liver disease. Lancet Gastroenterol Hepatol. 2017 06; 2(6):446-455.
Score: 0.425
-
Advanced cystic fibrosis liver disease: Endovascular, endoscopic, radiologic, and surgical considerations. Pediatr Pulmonol. 2024 Sep; 59 Suppl 1:S115-S122.
Score: 0.176
-
Prospective study of quantitative liver MRI in cystic fibrosis: feasibility and comparison to PUSH cohort ultrasound. Pediatr Radiol. 2023 10; 53(11):2210-2220.
Score: 0.163
-
Heterogeneous liver on research ultrasound identifies children with cystic fibrosis at high risk of advanced liver disease. J Cyst Fibros. 2023 07; 22(4):745-755.
Score: 0.160
-
Health-related Quality of Life in a Prospective Study of Ultrasound to Detect Cystic Fibrosis-related Liver Disease in Children. J Pediatr Gastroenterol Nutr. 2022 11 01; 75(5):635-642.
Score: 0.153
-
Our evolution in the treatment of hepatic artery and portal vein thrombosis in pediatric liver transplantation: Success with catheter-directed therapies. Pediatr Transplant. 2022 09; 26(6):e14306.
Score: 0.150
-
Severe Acute Respiratory Syndrome Coronavirus-2 Infection in Children With Liver Transplant and Native Liver Disease: An International Observational Registry Study. J Pediatr Gastroenterol Nutr. 2021 06 01; 72(6):807-814.
Score: 0.140
-
Biomarkers for liver disease in urea cycle disorders. Mol Genet Metab. 2021 06; 133(2):148-156.
Score: 0.139
-
Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency. JCI Insight. 2020 02 27; 5(4).
Score: 0.129
-
Heterogeneous Liver on Research Ultrasound Identifies Children with Cystic Fibrosis at High Risk of Advanced Liver Disease: Interim Results of a Prospective Observational Case-Controlled Study. J Pediatr. 2020 04; 219:62-69.e4.
Score: 0.128
-
Hepatic Steatosis Is Prevalent Following Orthotopic Liver Transplantation in Children With Cystic Fibrosis. J Pediatr Gastroenterol Nutr. 2019 01; 68(1):96-103.
Score: 0.119
-
MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis. Hepatology. 2018 12; 68(6):2301-2316.
Score: 0.118
-
SHIFTing goals in cystic fibrosis-managing extrapulmonary disease in the era of CFTR modulator therapy; Proceedings of the International Shaping Initiatives and Future Trends (SHIFT) Symposium. Pediatr Pulmonol. 2024 Jun; 59(6):1661-1676.
Score: 0.043
-
Imaging-based noninvasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline. Hepatology. 2025 Feb 01; 81(2):725-748.
Score: 0.043